Full Year 2018 CytomX Therapeutics Inc Earnings Call Transcript
Good afternoon, and welcome to the CytomX 2018 Full Year Financial Results Conference Call. (Operator Instructions) Please be aware that today's conference call is being recorded. I'd now like to turn the call over to Chris Keenan, CytomX's Vice President of Investor Relations. You may begin.
Good afternoon, and thank you for joining us for our 2018 Full Year Financial Results Conference Call.
Here with me today is CytomX President, Chief Executive Officer and Chairman, Dr. Sean McCarthy; and Debanjan Ray, our Chief Financial Officer.
Before we begin, I would like to remind you that we will be making forward-looking statements during the call. Because forward-looking statements relate to the future, they are subject to inherent uncertainties and risks that are difficult to predict and many of which are outside of our control. Important risks and uncertainties are set forth in our most recent public filings with the SEC at sec.gov, including our Form 10
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |